Paul Smalley - Oxford Cannabinoid F Director
OCTHF Stock | USD 0 0.00 0.00% |
Insider
Paul Smalley is F Director of Oxford Cannabinoid Technologies
Phone | 44 20 3034 2820 |
Web | https://www.oxcantech.com |
Similar Executives
Found 5 records | INSIDER Age | ||
Linda JD | Northwest Biotherapeutics | 67 | |
Jean Davis | Northwest Biotherapeutics | 51 | |
, MBA | Northwest Biotherapeutics | 64 | |
Stephen JD | Geron | 74 | |
David Innes | Northwest Biotherapeutics | N/A |
Oxford Cannabinoid Leadership Team
Elected by the shareholders, the Oxford Cannabinoid's board of directors comprises two types of representatives: Oxford Cannabinoid inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Oxford. The board's role is to monitor Oxford Cannabinoid's management team and ensure that shareholders' interests are well served. Oxford Cannabinoid's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Oxford Cannabinoid's outside directors are responsible for providing unbiased perspectives on the board's policies.
Indraneil Mahapatra, CoFounder Director | ||
Valentino Parravicini, Chief Officer | ||
John Lucas, CEO Director | ||
Eugenia Shostak, Ex Officer | ||
Clarissa SowemimoCoker, COO, CEO | ||
Paul Smalley, F Director |
Oxford Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Oxford Cannabinoid a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Current Valuation | (3.87 M) | |||
Shares Outstanding | 960.42 M | |||
Shares Owned By Insiders | 44.08 % | |||
Shares Owned By Institutions | 2.72 % | |||
Price To Book | 0.41 X | |||
Gross Profit | (3.15 M) | |||
EBITDA | (5.63 M) | |||
Book Value Per Share | 0.01 X | |||
Market Capitalization | 11.9 M |
Currently Active Assets on Macroaxis
Other Information on Investing in Oxford Pink Sheet
Oxford Cannabinoid financial ratios help investors to determine whether Oxford Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Oxford with respect to the benefits of owning Oxford Cannabinoid security.